NZ Rheumatology Research Review Issue 62

In this issue:
  -  Managing ICI-induced inflammatory arthritis: rheumatologists versus oncologists
  -  Long-term clinical outcomes for early RA treated-to-target
  -  Upadacitinib in early vs. established axial SpA
  -  Allopurinol use and ACS risk in gout
  -  Nonarticular pain at early RA diagnosis
  -  Sustained DMARD-free remission in RA subgroups
  -  Anxiety and depression in RA patients
  -  Baricitinib for early polymyalgia rheumatica
  -  Responsiveness/sensitivity of PROMs to disease activity changes in early and established RA
  -  Infliximab or adalimumab in refractory severe mucocutaneous Behçet’s syndrome

Please login below to download this issue (PDF)

Subscribe